Title : miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.

Pub. Date : 2017 Nov 15

PMID : 28928082






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin. Fluorouracil tumor protein p53 Homo sapiens
2 Evidence demonstrate that p53 mutations and microRNAs (miRs) are important components of 5-FU resistance in colorectal cancer (CRC). Fluorouracil tumor protein p53 Homo sapiens
3 Moreover, inhibition of miR-338-3p in HT29 and HCT116 p53-/- cells increased their sensitivity to 5-FU treatment. Fluorouracil tumor protein p53 Homo sapiens
4 Our results reveal a critical and novel role of miR-338-3p in the correlation of 5-FU resistance with p53 status. Fluorouracil tumor protein p53 Homo sapiens
5 Moreover, the miR-338-3p inhibitor has the potential to overcome 5-FU resistance in p53 mutant colon cancer cells. Fluorouracil tumor protein p53 Homo sapiens